U.K. Pharmaceuticals & Biotech Most Popular Stocks

Oxford BioDynamics

Market Cap: UK£9.3m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Cardiogeni

Market Cap: UK£8.0m

A clinical stage biotechnology company, develops heart failure medicines.

Cizzle Biotechnology Holdings

Market Cap: UK£7.1m

Operates as a cancer diagnostics company in the United Kingdom.

Genflow Biosciences

Market Cap: UK£7.0m

Engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.

Palatin Technologies

Market Cap: US$9.1m

A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

N4 Pharma

Market Cap: UK£5.7m

A specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom.

AIM ImmunoTech

Market Cap: US$7.6m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Proteome Sciences

Market Cap: UK£5.2m

Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.

Theracryf

Market Cap: UK£4.6m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Incanthera

Market Cap: UK£4.1m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

CRISM Therapeutics

Market Cap: UK£3.8m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Roquefort Therapeutics

Market Cap: UK£3.4m

A material biotech company, engages in the development of medicines for the treatment of cancer.

BSF Enterprise

Market Cap: UK£3.3m

Develops and commercializes cutting-edge tissue-engineered solutions.

Nuformix

Market Cap: UK£2.9m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

ValiRx

Market Cap: UK£2.3m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Physiomics

Market Cap: UK£1.5m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

genedrive

Market Cap: UK£1.4m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.